Sabra Health Care REIT, Inc. (SBRA)
NASDAQ: SBRA · Real-Time Price · USD
19.31
-0.30 (-1.53%)
At close: Aug 28, 2025, 4:00 PM
19.40
+0.09 (0.47%)
After-hours: Aug 28, 2025, 6:45 PM EDT
Sabra Health Care REIT Stock Forecast
Stock Price Forecast
The 8 analysts that cover Sabra Health Care REIT stock have a consensus rating of "Buy" and an average price target of $20.38, which forecasts a 5.54% increase in the stock price over the next year. The lowest target is $18 and the highest is $22.
Price Target: $20.38 (+5.54%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Sabra Health Care REIT stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 3 | 3 | 3 | 3 | 3 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $20 → $21 | Buy | Maintains | $20 → $21 | +8.75% | Aug 27, 2025 |
| BMO Capital | BMO Capital | Hold Maintains $19 → $22 | Hold | Maintains | $19 → $22 | +13.93% | Aug 25, 2025 |
| JMP Securities | JMP Securities | Buy Maintains $20 → $22 | Buy | Maintains | $20 → $22 | +13.93% | Aug 6, 2025 |
| Scotiabank | Scotiabank | Hold Maintains $19 → $20 | Hold | Maintains | $19 → $20 | +3.57% | Jun 23, 2025 |
| Scotiabank | Scotiabank | Hold Maintains $18 → $19 | Hold | Maintains | $18 → $19 | -1.61% | May 12, 2025 |
Financial Forecast
Revenue This Year
748.23M
from 702.64M
Increased by 6.49%
Revenue Next Year
804.34M
from 748.23M
Increased by 7.50%
EPS This Year
0.74
from 0.54
Increased by 37.26%
EPS Next Year
0.79
from 0.74
Increased by 6.65%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 821.0M | 992.7M | |||
| Avg | 748.2M | 804.3M | |||
| Low | 692.3M | 716.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 16.8% | 32.7% | |||
| Avg | 6.5% | 7.5% | |||
| Low | -1.5% | -4.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.86 | 0.88 | |
| Avg | 0.74 | 0.79 | |
| Low | 0.67 | 0.72 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 59.4% | 19.0% | |
| Avg | 37.3% | 6.7% | |
| Low | 23.4% | -3.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.